Home » Newsletters » BioWorld

BioWorld

April 23, 2001

View Archived Issues

SYN X Plans Offering To Raise Up To C$20M For Programs

Genelabs Shares Bounce Back As Fate Of Aslera Still Uncertain

Correction

U.S. Patent Disclosures

Other News To Note

MedImmune, Genaera Collaborate On IL-9 Therapeutics For Asthma

Genentech, Actelion See Negative Results in RITZ-1 Pivotal Phase III

Not By Drugs Alone: Third World Needs Effective Vaccines To Curb Rampant African AIDS Pandemic

Vical Ends Leuvectin Phase II, Plans Another At Higher Dose

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.